Literature DB >> 24282022

Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass.

Martin S Neergaard1, Anders D Nielsen, Henrik Parshad, Marco Van De Weert.   

Abstract

Few studies have so far directly compared the impact of antibody subclass on protein stability. This case study investigates two mAbs (one IgG1 and one IgG4 ) with identical variable region. Investigations of mAbs that recognize similar epitopes are necessary to identify possible differences between the IgG subclasses. Both physical and chemical stability were evaluated by applying a range of methods to measure formation of protein aggregates [size-exclusion chromatography (SEC)-HPLC and UV340 nm], structural integrity (circular dichroism and FTIR), thermodynamic stability (differential scanning calorimetry), colloidal interactions (dynamic light scattering), and fragmentation and deamidation (SEC-HPLC and capillary isoelectric focusing). The impact of pH (4-9) and ionic strength (10 and 150 mM) was investigated using highly-concentrated (150 mg/mL) mAb formulations. Lower conformational stability was identified for the IgG4 resulting in increased levels of soluble aggregates. The IgG1 was chemically less stable as compared with the IgG4 , presumably because of the higher flexibility in the IgG1 hinge region. The thermodynamic stability of individual mAb domains was also addressed in detail. The stability of our mAb molecules is clearly affected by the IgG framework, and this study suggests that subclass switching may alter aggregation propensity and aggregation pathway and thus potentially improve the overall formulation stability while retaining antigen specificity.
© 2013 Wiley Periodicals, Inc. and the American Pharmacists Association.

Keywords:  chemical stability; high concentration; monoclonal antibody; physical stability; protein aggregation; protein formulation; protein-protein interactions; thermal analysis

Mesh:

Substances:

Year:  2013        PMID: 24282022     DOI: 10.1002/jps.23788

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  24 in total

1.  In vitro and in silico assessment of the developability of a designed monoclonal antibody library.

Authors:  Adriana-Michelle Wolf Pérez; Pietro Sormanni; Jonathan Sonne Andersen; Laila Ismail Sakhnini; Ileana Rodriguez-Leon; Jais Rose Bjelke; Annette Juhl Gajhede; Leonardo De Maria; Daniel E Otzen; Michele Vendruscolo; Nikolai Lorenzen
Journal:  MAbs       Date:  2019-01-18       Impact factor: 5.857

2.  Acid-induced aggregation propensity of nivolumab is dependent on the Fc.

Authors:  Boning Liu; Huaizu Guo; Jin Xu; Ting Qin; Lu Xu; Junjie Zhang; Qingcheng Guo; Dapeng Zhang; Weizhu Qian; Bohua Li; Jianxin Dai; Sheng Hou; Yajun Guo; Hao Wang
Journal:  MAbs       Date:  2016-06-16       Impact factor: 5.857

3.  Experimental Model System to Study pH Shift-Induced Aggregation of Monoclonal Antibodies Under Controlled Conditions.

Authors:  Olubukayo-Opeyemi Oyetayo; Hans Kiefer
Journal:  Pharm Res       Date:  2016-02-29       Impact factor: 4.200

4.  L445P mutation on heavy chain stabilizes IgG4 under acidic conditions.

Authors:  Chang-Ai Xu; Andrew Z Feng; Charan K Ramineni; Matthew R Wallace; Elizabeth K Culyba; Kevin P Guay; Kinjal Mehta; Robert Mabry; Stephen Farrand; Jin Xu; Jianwen Feng
Journal:  MAbs       Date:  2019-07-11       Impact factor: 5.857

5.  Physicochemical Rules for Identifying Monoclonal Antibodies with Drug-like Specificity.

Authors:  Yulei Zhang; Lina Wu; Priyanka Gupta; Alec A Desai; Matthew D Smith; Lilia A Rabia; Seth D Ludwig; Peter M Tessier
Journal:  Mol Pharm       Date:  2020-06-11       Impact factor: 4.939

6.  Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.

Authors:  Youngbin Baek; Nripen Singh; Abhiram Arunkumar; Andrew L Zydney
Journal:  Pharm Res       Date:  2016-12-29       Impact factor: 4.200

7.  Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics.

Authors:  Sahithi Ravuluri; Rohit Bansal; Nidhi Chhabra; Anurag S Rathore
Journal:  Pharm Res       Date:  2018-05-14       Impact factor: 4.200

Review 8.  Challenges and Opportunities for the Subcutaneous Delivery of Therapeutic Proteins.

Authors:  Michael R Turner; Sathy V Balu-Iyer
Journal:  J Pharm Sci       Date:  2018-01-11       Impact factor: 3.534

9.  Comparative Effects of Metal-Catalyzed Oxidizing Systems on Carbonylation and Integrity of Therapeutic Proteins.

Authors:  Dmitry Kryndushkin; V Ashutosh Rao
Journal:  Pharm Res       Date:  2015-10-23       Impact factor: 4.200

10.  Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regions.

Authors:  Jasmin F Sydow; Florian Lipsmeier; Vincent Larraillet; Maximiliane Hilger; Bjoern Mautz; Michael Mølhøj; Jan Kuentzer; Stefan Klostermann; Juergen Schoch; Hans R Voelger; Joerg T Regula; Patrick Cramer; Apollon Papadimitriou; Hubert Kettenberger
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.